Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × Drug Therapy × Clear all

NCT01094496 2020-02-13

A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

Phase 2 Terminated

Urinary Bladder Neoplasms, Urogenital Neoplasms

NCT00006376 2013-12-04

R115777 in Treating Patients With Advanced Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms